Chemical Structure (Polymyxin 01)
Polymyxin B Injection, Powder, For Solution
Product Images NDC 70594-049
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 70594-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (500,000 unit Vial Carton)
Polymyxin B for Injection, USP in 10 sterile vials. Each vial contains 500,000 units of Polymyxin B Sulfate, for intramuscular, intravenous, and/or intrathecal administration for hospital use only with caution. The drug may be nephrotoxic and neurotoxic, and dosages should not exceed 25,000 units per kg per day. Before reconstitution, it should be stored at 20° to 25°C (68° to 77°F), and after reconstitution product must be stored between 2° to 8°C (36° to 46°F) with a 72-hour shelf life. Made in Hyderabad, Telangana, India for Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089. Available in packs of 10 vials of 500,000 units each by NDC-70594-049-02.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
